---
title: "Iovance (IOVA) hits 52-week high as analyst doubles price target"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278201849.md"
description: "Iovance Biotherapeutics Inc. (NASDAQ:IOVA) reached a new 52-week high, continuing a three-day surge as investors bought shares following an investment firm's decision to double its price target for the stock. The company is currently listed among the 10 Stocks to Watch."
datetime: "2026-03-07T06:51:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278201849.md)
  - [en](https://longbridge.com/en/news/278201849.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278201849.md)
---

# Iovance (IOVA) hits 52-week high as analyst doubles price target

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the 10 Stocks to Watch Right Now. Iovance climbed to a new 52-week high on Friday, extending a three-day run, as investors gobbled up shares after an investment firm doubled its price target for its stock. At intra-day trading, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) climbed to its highest price \[…\]

### Related Stocks

- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IOVA.US](https://longbridge.com/en/quote/IOVA.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [Roth MKM Reaffirms Their Buy Rating on Equillium (EQ)](https://longbridge.com/en/news/283066157.md)
- [BUZZ-Cancer biotech Adlai Nortye jumps after $150 mln equity financing](https://longbridge.com/en/news/282996483.md)
- [BUZZ-Street View: Analysts upbeat on Revolution pancreatic cancer drug](https://longbridge.com/en/news/282702171.md)
- [FDA Rejection Sparks Questions On Replimune Drug Approval Path](https://longbridge.com/en/news/282577359.md)
- [This Inhibrx Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday](https://longbridge.com/en/news/282051007.md)